Comparison between frovatriptan plus different treatment regimens of dexketoprofen (25 mg and 37.5 mg) and frovatriptan alone in the acute treatment of migraine without aura and migraine with aura attacks.

Trial Profile

Comparison between frovatriptan plus different treatment regimens of dexketoprofen (25 mg and 37.5 mg) and frovatriptan alone in the acute treatment of migraine without aura and migraine with aura attacks.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2014

At a glance

  • Drugs Dexketoprofen (Primary) ; Frovatriptan
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2013 Results presented at the 2013 International Headache Congress .
    • 27 Jun 2013 Results from a pre-defined subgroup analysis (women with menstrual-related migraine) presented at the 2013 International Headache Congress .
    • 16 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top